Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomohisa Baba

Showing results (191-200 of 249) with videos related to

Pageof 25
Sort By:
Blood|March 18, 2009
Exclusive expression of proteasome subunit {beta}5t in the human thymic cortexUtano Tomaru, Akihiro Ishizu, Shigeo Murata, et al.
Respiratory Investigation|June 26, 2021
Asbestos exposure and tuberculous pleurisy as developmental causes of progressive unilateral upper-lung field pulmonary fibrosis radiologically consistent with pleuroparenchymal fibroelastosisAkimasa Sekine, Eri Hagiwara, Tae Iwasawa, et al.
BMC Pulmonary Medicine|April 13, 2019
Negative impact of anorexia and weight loss during prior pirfenidone administration on subsequent nintedanib treatment in patients with idiopathic pulmonary fibrosisSatoshi Ikeda, Akimasa Sekine, Tomohisa Baba, et al.
Respiratory Investigation|June 9, 2023
Utility of budgerigar/pigeon/parrot-specific IgG antibody with ImmunoCAP® in bird-related hypersensitivity pneumonitis caused by other bird species and duvetTsuyoshi Shirai, Yoshinori Tanino, Takefumi Nikaido, et al.
Respiratory Medicine|September 10, 2020
The potential utility of anterior upper lobe honeycomb-like lesion in interstitial lung disease associated with connective tissue diseaseHideaki Yamakawa, Takashi Ogura, Shintaro Sato, et al.
Scientific Reports|September 9, 2017
Low body surface area predicts hepatotoxicity of nintedanib in patients with idiopathic pulmonary fibrosisSatoshi Ikeda, Akimasa Sekine, Tomohisa Baba, et al.
Investigational New Drugs|February 22, 2019
Phase I study of TAS-121, a third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, in patients with non-small-cell lung cancer harboring EGFR mutationsMakoto Nishio, Haruyasu Murakami, Yuichiro Ohe, et al.
Cancers|April 13, 2024
<i>KRAS</i> Inhibitor as a Treatment Option for Non-Small-Cell Lung Cancer with Comorbid Interstitial PneumoniaKazushi Fujimoto, Satoshi Ikeda, Erina Tabata, et al.
Allergology International : Official Journal of the Japanese Society of Allergology|October 12, 2020
Screening and diagnosis of acute and chronic bird-related hypersensitivity pneumonitis by serum IgG and IgA antibodies to bird antigens with ImmunoCAP®Tsuyoshi Shirai, Yoshinori Tanino, Takefumi Nikaido, et al.
Medicine|June 6, 2022
Randomized phase II study of nintedanib with or without pirfenidone in patients with idiopathic pulmonary fibrosis who experienced disease progression during prior pirfenidone administrationSatoshi Ikeda, Akimasa Sekine, Tomohisa Baba, et al.
Pageof 25

Showing results (191-200 of 249) with videos related to

Sort By:
Pageof 25
Blood|March 18, 2009
Exclusive expression of proteasome subunit {beta}5t in the human thymic cortexUtano Tomaru, Akihiro Ishizu, Shigeo Murata, et al.
Respiratory Investigation|June 26, 2021
Asbestos exposure and tuberculous pleurisy as developmental causes of progressive unilateral upper-lung field pulmonary fibrosis radiologically consistent with pleuroparenchymal fibroelastosisAkimasa Sekine, Eri Hagiwara, Tae Iwasawa, et al.
BMC Pulmonary Medicine|April 13, 2019
Negative impact of anorexia and weight loss during prior pirfenidone administration on subsequent nintedanib treatment in patients with idiopathic pulmonary fibrosisSatoshi Ikeda, Akimasa Sekine, Tomohisa Baba, et al.
Respiratory Investigation|June 9, 2023
Utility of budgerigar/pigeon/parrot-specific IgG antibody with ImmunoCAP® in bird-related hypersensitivity pneumonitis caused by other bird species and duvetTsuyoshi Shirai, Yoshinori Tanino, Takefumi Nikaido, et al.
Respiratory Medicine|September 10, 2020
The potential utility of anterior upper lobe honeycomb-like lesion in interstitial lung disease associated with connective tissue diseaseHideaki Yamakawa, Takashi Ogura, Shintaro Sato, et al.
Scientific Reports|September 9, 2017
Low body surface area predicts hepatotoxicity of nintedanib in patients with idiopathic pulmonary fibrosisSatoshi Ikeda, Akimasa Sekine, Tomohisa Baba, et al.
Investigational New Drugs|February 22, 2019
Phase I study of TAS-121, a third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, in patients with non-small-cell lung cancer harboring EGFR mutationsMakoto Nishio, Haruyasu Murakami, Yuichiro Ohe, et al.
Cancers|April 13, 2024
<i>KRAS</i> Inhibitor as a Treatment Option for Non-Small-Cell Lung Cancer with Comorbid Interstitial PneumoniaKazushi Fujimoto, Satoshi Ikeda, Erina Tabata, et al.
Allergology International : Official Journal of the Japanese Society of Allergology|October 12, 2020
Screening and diagnosis of acute and chronic bird-related hypersensitivity pneumonitis by serum IgG and IgA antibodies to bird antigens with ImmunoCAP®Tsuyoshi Shirai, Yoshinori Tanino, Takefumi Nikaido, et al.
Medicine|June 6, 2022
Randomized phase II study of nintedanib with or without pirfenidone in patients with idiopathic pulmonary fibrosis who experienced disease progression during prior pirfenidone administrationSatoshi Ikeda, Akimasa Sekine, Tomohisa Baba, et al.
Pageof 25